CellRep Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $200K

  • Investors
  • 5

CellRep General Information

Description

Developer of an artificial intelligence-driven cell reprogramming platform designed to improve T-cell function during the manufacturing of cell therapies. The company offers small molecules that temporarily alter T-cell states during ex vivo manufacturing, supported by computational target discovery and laboratory and animal testing, enabling cell therapy developers and treatment centres to produce CAR-T cells with improved functionality and sustained antitumor activity.

Contact Information

Website
www.cellrep.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Houston, TX 77030
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Discovery Tools (Healthcare)
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Oncology
Corporate Office
  • Houston, TX 77030
  • United States

CellRep Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellRep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Dec-2025 $200K Completed Startup
2. Angel (individual) 07-May-2025 Completed Startup
1. Accelerator/Incubator Completed Startup
To view CellRep’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CellRep Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

CellRep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026231497-A1 Methods and systems for cell reprogramming Pending 28-Apr-2025
WO-2026226368-A1 Method for modulating nur77 in cd8+ t cells to enhance their therapeutic potential and applications thereof Pending 25-Apr-2025

CellRep Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellRep Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIR Capital Venture Capital Minority
Grid Exponential Accelerator/Incubator Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
To view CellRep’s complete investors history, request access »

Ready to get started?

Request a free trial

CellRep FAQs

  • When was CellRep founded?

    CellRep was founded in 2024.

  • Where is CellRep headquartered?

    CellRep is headquartered in Houston, TX.

  • What is the size of CellRep?

    CellRep has 8 total employees.

  • What industry is CellRep in?

    CellRep’s primary industry is Biotechnology.

  • Is CellRep a private or public company?

    CellRep is a Private company.

  • What is the current valuation of CellRep?

    The current valuation of CellRep is .

  • What is CellRep’s current revenue?

    The current revenue for CellRep is .

  • How much funding has CellRep raised over time?

    CellRep has raised $480K.

  • Who are CellRep’s investors?

    AIR Capital, Grid Exponential, , , and have invested in CellRep.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process